Baral R, Luo X, Watanabe H, Yamasawa I, Ibukiyama C
Second Department of Internal Medicine, Tokyo Medical College.
Intern Med. 1994 Apr;33(4):210-5. doi: 10.2169/internalmedicine.33.210.
In addition to electrocardiogram (ECG), analysis of creatinine phosphokinase (CPK), lactate dehydrogenase (LDH) and their isoenzymes is commonly employed to diagnose acute myocardial infarction (AMI). The aim of this study was to observe the efficiency of isomers of CPK for early diagnosis of AMI. ECG, though useful in many ways, is not 100% sensitive. The drawback involved with CPK and LDH isoenzymes is the time lag factor in diagnosing AMI early enough for interventional therapy. Recently the subunits of these isoenzymes, namely MM and now the MB isomers are being tested for their effectiveness in the early diagnosis of AMI. In our experience MB isomers were found to be accurate markers in the early diagnosis of AMI. They were especially valuable in diagnosing myocardial infarction not detectable by ECG in cases such as non-Q AMI, cardiomyopathy, and bundle branch block among other such cases.
除心电图(ECG)外,肌酸磷酸激酶(CPK)、乳酸脱氢酶(LDH)及其同工酶的分析也常用于诊断急性心肌梗死(AMI)。本研究的目的是观察CPK异构体对AMI早期诊断的效能。心电图虽在很多方面有用,但并非100%敏感。CPK和LDH同工酶存在的缺点是在足够早期诊断AMI以进行介入治疗方面存在时间滞后因素。最近,这些同工酶的亚基,即MM以及现在的MB异构体正在接受检测,以评估其在AMI早期诊断中的有效性。根据我们的经验,发现MB异构体是AMI早期诊断的准确标志物。在诊断非Q波型AMI、心肌病和束支传导阻滞等其他病例中,心电图无法检测到的心肌梗死时,它们尤其有价值。